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Abstract
Background: Enhancing patient participation is becoming increasingly important in mental health care as patients
use to have a dependent, inactive role and nonadherence to treatment is a regular problem. Research shows
promising results of initiatives stimulating patient participation in partnership with their clinicians. However, few
initiatives targeting both patients’ and clinicians’ behaviour have been evaluated in randomised trials (RCT).
Therefore, in GGz Breburg, a specialized mental health institution, a digital intake approach was developed aimed at
exploring treatment needs, expectations and preferences of patients intended to prepare patients for the intake
consultations. Subsequently, patients and clinicians discuss this information during intake consultations and make
shared decisions about options in treatment. The aim of this trial is to test the efficacy of this new digital intake
approach facilitated by Routine Outcome Monitoring (ROM), peer support and training of clinicians as compared to
the intake as usual. The primary outcome is decisional conflict about choices in treatment. Secondary outcomes
focus on patient participation, shared decision making, working alliance, adherence to treatment and clinical
outcomes.
Methods: This article presents the study protocol of a cluster-randomised controlled trial in four outpatient
departments for adults with depression, anxiety and personality disorders, working in two different regions.
Randomisation is done between two similar intake-teams within each department. In the four intervention teams
the new intake approach is implemented. The four control teams apply the intake as usual and will implement the
new approach after the completion of the study. In total 176 patients are projected to participate in the study. Data
collection will be at baseline, and at two weeks and two months after the intake.
Discussion: This study will potentially demonstrate the efficacy of the new digital intake approach in mental health
care in terms of the primary outcome the degree of decisional conflict about choices in treatment. The findings of
this study may contribute to the roll out of such eHealth initiatives fostering patient involvement in decision
making about their treatment.
Trial registration: Trial registration: Dutch Trial Register NTR5677. Registered 17th January 2016.
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Background
The enhancement of patient participation in health care
is deemed to be of great importance [1–3]. Research has
pointed out that patients who take an active role in their
treatment are often more satisfied and feel more in
control with the health care they receive, are more able
to manage their own mental health, have better treat-
ment adherence, report a higher quality of life, and show
better health outcomes [4–10].
Despite the importance of patient participation, the
literature offers no univocal definition of this concept
[10, 11]. In this study we choose the most commonly
used definition of patient participation, referring to pa-
tient involvement in decision making about their health
care [10, 12]. This way, patient participation, which in-
cludes behaviours such as providing information, asking
questions and preparing for consultations, is an issue
closely related to Shared Decision Making (SDM) [13].
SDM is defined as a collaborative approach in which cli-
nicians and patients share the best available information
when making clinical decisions, and where patients are
supported to consider options to achieve informed pref-
erences [14]. In Dutch mental health care, the import-
ance of patient participation is emphasized by a range of
initiatives aimed at stimulating Shared Decision Making
[15–18]. There is growing evidence of the benefits of
SDM in mental health care. Research has shown that
SDM in mental health care leads to better informed and
more actively engaged patients, more patient satisfac-
tion, less decisional conflict and better patient treatment
adherence [19–29].
In spite of the interest and the potential of SDM
approaches in mental health care, to date many patients
still have a dependent, inactive role in mental health
treatment, believing ‘clinicians know best’ and expecting
clinicians to make decisions in treatment [15, 16, 28–31].
Fostering patient engagement and SDM in mental
health care is, therefore, essential. More initiatives are
needed to support the decisional capacity, participation
and active behaviour of patients in treatment granting
them more choice and control regarding their own
mental health care, to provide a more equitable and
collaborative working relationship and to enhance
shared decision making [1, 4, 13, 32].
Previous studies have shown that both the attitudes of
clinicians and patients influence patient participation
and joint decision making [8, 13, 30, 33–35]. The power
imbalance between patients and clinicians is deemed to
be a key barrier in making shared decisions [36]. Few
initiatives targeting both patients’ and clinicians’
behaviour have been conducted and evaluated [33].
This underlines the need for new initiatives that aim
to support patients as well as to modify clinicians’
attitudes [13, 35, 36].
It should be noted, however, that not all patients are
equally capable to participate in their treatment process.
Adequately fulfilling this role depends on interests, skills
and support that patients receive [4, 5]. Furthermore,
the patient-clinician working alliance has a great influ-
ence on the degree of patient participation in decision
making [37, 38]. The working alliance between patient
and clinician refers to the collaborative relationship be-
tween patient and clinicians and includes communica-
tion style, the quality of the relationship, agreement on
goals and tasks and mutual decision making [37–41].
The patient-clinician relationship is an important basis
for sharing treatment decisions [37, 38]. Several studies
have demonstrated the positive correlation between the
quality of the patient-clinician alliance with treatment
adherence and clinical outcomes [9, 40, 42, 43].
Rationale
As described above, a reversal in the current practice,
focused on attitudinal changes at the level of patients as
well as clinicians from the start of treatment on, is
needed to mobilise and facilitate patients to participate
in mental health treatment. Therefore, GGz Breburg, a
specialized mental health institute in the southern part
of the Netherlands, will implement a digital intake
approach incorporating eHealth interventions integrated
with Routine Outcome Monitoring, which implies regu-
lar measurements of clinical outcomes during treatment
(for details see page 7), and facilitated by consultation of
peers and clinicians’ training. It aims to explore treat-
ment needs, expectations and preferences of patients
and discussing this information with the clinicians
during intake consultations. This digital intake approach
is expected to influence both sides of the therapeutic
dyad in a positive way and will be implemented in four
outpatient departments, for adults with depression,
anxiety and personality disorders. Such a combined
initiative in the intake process has not been tested in a
randomised controlled trial.
Aim and hypotheses
Aim of this trial is to test the efficacy of a digital explor-
ation of patients’ treatment preferences at intake facilitated
by Routine Outcome Monitoring (ROM), peer support and
training of clinicians in terms of the primary outcome the
degree of decisional conflict, as an important result of pa-
tient participation and shared decision making [26, 44].
This manuscript will report on the development of this
new digital intake approach and the design of the study
that will be conducted to evaluate this approach.
The first hypothesis is that, compared to the intake as
usual, the new intake method will lead to less decisional
conflict about choices in treatment. The second hypothesis
is that the implementation of the new intake method
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enhances patient participation, stimulates the process of
shared decision making, improves the working alliance
between patients and clinicians, and finally has positive ef-
fects on the adherence to treatment and clinical outcomes.
Methods/Design
Trial design
This study is designed as a two-arm matched-pair cluster-
randomised controlled trial with two conditions: 1. A
digital intake process with eHealth interventions inte-
grated with two consecutive Routine Outcome Monitor-
ing (ROM) measurements and consultation of peers
supporting patients to participate from the beginning of
treatment along with training and coaching of clinicians
to adopt the changing roles; 2. The intake as usual with a
single ROM measurement and without eHealth interven-
tions, peer support and training of clinicians. The control
teams will implement the new intake process after the
completion of the data-collection.
Participants and setting
This study will be conducted in four outpatient depart-
ments of a specialised mental health institution GGz
Breburg, located in the southern part of the Netherlands.
Annually, more than 14.000 patients are treated by about
2000 employees at GGz Breburg. The digital intake ap-
proach will be being tested among various diagnostic
groups (patients with depression, anxiety and personality
disorders as their primary diagnosis). Two of the partici-
pating departments are specialised in treating patients
with depression and anxiety disorders; each operating in a
separate geographical catchment area. The other two
departments are specialised in personality disorders and
are active in separate catchment areas. The four partici-
pating departments are each divided into two teams of
clinicians who perform intakes (Fig. 1). Each team of
intake-clinicians have their own multidisciplinary team
consultation, in which treatment policy at the patient level
is discussed and checked. Due to the matched pair design
at the level of intake-teams within each department, in
total four intervention and four control teams participate.
In accordance to the sample size calculation (see section
sample size, page 18) 176 patients will be included (88 in
the intervention and 88 in the control teams), with an
average of 44 patients per department (22 intervention
and 22 control).
Inclusion and exclusion
Patients from the participating departments will be
invited for participation in this study if a) a full intake is
planned and b) when they are fluent in Dutch. Patients
who meet these criteria will be asked for written
informed consent. Patients will be excluded form the
study if they do not receive a full intake and do not have
adequate Dutch language skills (verbal and written).
Randomisation and blinding
A cluster randomised design at the level of intake-teams
and participation of intake-teams in separate multidis-
ciplinary consultations will serve to limit contamination
effects between intervention and control groups [45].
The pairs of intake groups within a department are ran-
domly assigned to either the experimental or control
condition (matched pairs). The matched teams within
each department perform intakes for a similar popula-
tion of patients in a similar geographic catchment area
and have similar personnel. Randomisation of the
intake-teams is conducted by an independent researcher,
using a syntax in SPSS, which allocates the matched
pairs to the control (code 0) or intervention group (code
1). To reduce bias, data collection for this study will be
carried out by research assistants, independent of the
principal investigator and treatment, with self-report in-
struments completed by both patients and clinicians.
This results are not visible at patient level during intake
and treatment. Only the outcome parameters no-show,
drop-out and clinical outcome (ROM) will be collected
in the context of treatment. As is common practice in
cluster randomised RCTs, propensity analyses will be
performed at the analytical stage to correct for possible
biases in the randomisation process [45].
During inclusion, while informing patients and asking
them for written informed consent, the research assis-
tants are blinded for the study arm. The questionnaires
Fig. 1 Participating departments and intake teams
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are based on self report and hence do not require assess-
ment by a research assistant. Due to the randomisation
at the team level and the nature of the intervention,
blinding of the clinicians and patients is impossible.
Intervention and control
The intervention teams implement an intake interven-
tion consisting of four parts: eHealth modules, Routine
Outcome Monitoring, peer support and training of
clinicians.
Firstly, eHealth modules are an accessible way for pa-
tients to prepare the face to face consultations together
with relatives, offer opportunities for patients to partici-
pate actively in treatment and support shared decision
making [46–48]. Secondly, Routine Outcome Monitor-
ing (ROM) is integral part of the digital intake approach.
ROM implies regular measurement of clinical outcomes,
at the beginning, during and at the end of treatment,
aiming to provide feedback (e.g. with graphics) on the
patients’ progress during treatment and use the informa-
tion to adjust treatment [49–52]. At the intake (and later
on during treatment), ROM is a useful tool to involve
patients in their treatment process by means of provid-
ing information by which shared decisions are made
about treatment [18, 53]. In this initiative, ROM results
visualised in a graphic environment, are presented as
‘the recovery trajectory of the patient’. The participating
departments all use the same ROM questionnaire which
measures symptoms and functioning. Two ROM mea-
surements in the intake process may contribute to
meaningful results which are not dependent on a single
measurement point. Thirdly, the availability of peers for
counselling is a promising approach empowering pa-
tients to participate in treatment [54]. Finally, training of
clinicians and follow-up training sessions take place to
stimulate and facilitate the requested changing roles of
clinicians and patients [36] in the new intake approach.
The eHealth modules are designed to explore treat-
ment needs, expectations and preferences of patients.
With these modules patients prepare themselves, along
with relatives, for the face to face intake consultations,
which are intended to lower decisional conflict, stimu-
late patient participation and facilitate the dialogue be-
tween patients and clinicians about choices in treatment.
The content of the eHealth modules is described in
Table 1.
In Fig. 2 the usual and new digital intake-processes are
described. Patients of the intervention group follow the
first pre-intake module before the first face to face in-
take consultation and the second module just after the
first and before the second face to face intake consult-
ation. Patients follow the eHealth modules at home on
their own device, a computer or tablet. The estimated
time for completing each module is 45 min. While filling
out the eHealth modules, patients get the opportunity to
have contact with peers (by phone or mail) who can sup-
port and prepare them for the intake consult. Peers have
life experience with mental illness and treatment. They
are already working at GGz Breburg and are experts in
supporting patients. They have completed specific edu-
cation about how to support patients using their experi-
ence in mental health care and get also instruction in
the way to assist patients who are following eHealth. To
prepare for the first consultation, the completed mod-
ules are visible for both the patient and the clinician.
During this first intake consultation patients and clini-
cians discuss results of the first pre-intake module by
exploring the burden and impact of the mental health
problems on daily life. During the second face to face
consultation patient and clinician complete, using the re-
sults of the second module, the exploration about prob-
lems, coping and goals and take shared decisions about
the treatment policy and goals. After the second intake
consultation the treatment starts. In both conditions the
number of face to face contacts in the intake procedure
are the same. To make sure that patients and clinicians
have sufficient time to discuss the results of the eHealth
module, in the new intake approach the first intake
consult will take 30 min longer. Because ROM is a
promising tool which visualises symptoms severity and
functioning, stimulates effective communication between
Table 1 Content of intake eHealth modules
First module a pre-intake intervention (before the first intake consultation):
- Patients are informed about psychiatric symptoms and the influence
on daily life (e.g. with animations).
- Patients work on questions about their life events, symptoms, the
burden and impact of the mental health problems on daily life
(before and after the symptoms) and the urgency which problem
changing first. Preferably, this preparation takes place together
with a relative.
- Routine Outcome Monitoring (ROM) is integral part of the eHealth
module.
- Patients and clinicians, who perform intakes, get a summary of the
degree of (dis)satisfaction about life domains, burden of symptoms
and the recovery line (ROM).
- During participation in the eHealth module, patients get the
opportunity to contact with peers (by phone or mail) who can
support and prepare them for the intake consult.
Second module between first and second intake consultation:
- Prior to the second face to face consultation, patients look back on
the results of the first module and face to face intake consultation.
The summary of this first step could be supplemented with new
insights. In addition, patients work on questions about the most
burdening mental health problem and their own coping style
(i.e. type of coping, how to mobilise individual resources). Relatives
are asked to answer some of these questions from their
perspectives. Finally, the patient starts with preparing their own
treatment goals.
- Equal to the first module, contacting peers is also possible while
following the second module.
- When the module is completed, patients and clinicians will also get
a summary of the answered questions.
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patients and clinicians and empowers patients [49, 53] in
the new digital intake approach an additional ROM
moment is planned. While the intake as usual includes a
single ROM measurement linked to the face to face
intake consultation, the new intake approach includes
two measurements: one measurement incorporated in
the first eHealth module and one, as usual, linked to the
face to face intake consultation. In both conditions the
multidisciplinary team consultation keeps a role in
checking the quality and appropriateness of the proposed
treatment and process steps, according to multidisciplin-
ary guidelines.
To stimulate and facilitate the new way of working in
the digital intake, the clinicians of the intervention teams
follow a training of three half-day sessions in a period of
up to four weeks. Aim of this training is gaining insight,
knowledge and skills in the application of recovery sup-
ported care, shared decision making and eHealth with
the purpose to facilitate patients to participate in their
intake and treatment process and to stimulate an equiva-
lent interplay between patients and clinicians. During
the course of the study at least two follow-up training
meetings are organised in the intervention group aimed
to discuss clinicians’ experiences with the new way of
working.
Study flow
Patients who are referred to one of the participating
departments, are invited for an intake consult. Patients
who are planned for an intake consultation with a
clinician of the intervention group, are assigned to the
intervention team and will get the new eHealth intake
automatically. Patients who have this first appointment
with a clinician of the control group, are assigned to the
control group and will follow the intake as usual. In
addition, both groups of patients, who follow the new
intake process and the intake as usual, will be invited to
participate in the evaluation research consecutively.
Research assistants inform all patients (who meet the
inclusion criteria) about the research, ask them to
participate in the study and obtain written informed
consent.
Three measurement points will be scheduled (see
Table 2): baseline assessment (T0) and two measure-
ments (T1, T2) after the intake (T1 = two weeks after
intake, T2 = two months after intake). Because only T1
and T2 contains additional questionnaires for this
research, written informed consent will be asked during
the first face to face appointment, just before T1.
Patients who give informed consent for the research,
are completing self-report questionnaires organised by
independent research assistants. In addition to T1,
clinicians answer questions about shared decision
making regarding their patients. Patients and clinicians
who participate in the study, receive a request by email to
complete the questionnaires. If necessary, one week later
they get a reminder by email. After nine and fourteen days
the research assistant calls patients who have not yet
Fig. 2 Digital intake process compared to intake as usual
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completed the questionnaires. Patients who do not use
internet, receive paper questionnaires by mail.
Outcome measures
The outcomes of interests will be decisional conflict
(primary outcome), patient participation, shared decision
making process, working alliance between patient and
clinician, adherence to treatment and clinical outcome
(secondary outcomes). The outcome measures are visua-
lised in Fig. 3 and the measurement points in Table 2.
The level of decisional conflict is closely related to the
secondary outcome parameters patient participation in
treatment, shared decision making process and working
alliance. Less decisional conflict is associated with more
patient participation in decision making about treat-
ment, a better shared decision making process and
equality in the working alliance [26, 44, 54].
Patients’ characteristics
At baseline the following characteristics of patients are
registered: socio-demographics (sex, age and educational
level), diagnosis, SQ-48 (ROM) score, previous treat-
ment, length of waiting time and the motivation to start
treatment (own initiative or by pressure of the social
environment). At T2, patients will receive a self-report
questionnaire with a single question about the extent to
which their personal treatment goals have been achieved.
This question has three response categories (yes, partially,
no).
EPR ¼ Electronical Patient Records
Primary outcome measure
The primary outcome measure is the degree of deci-
sional conflict a central determinant of decision making,
which is defined as ‘personal uncertainty about which
option to choose’ [55, 56], will be measured with the
translated Decisional Conflict Scale (DCS) [18, 55]. The
DCS is a self-report questionnaire comprising sixteen
questions about personal perceptions of: uncertainty in
choosing options, modifiable factors contributing to
uncertainty, effective decision making such as feeling the
choice is informed, values-based, likely to be imple-
mented and expressing satisfaction with the choice [55].
Each item is measured on a 5-point Likert scale (0 =
strongly agree to 4 = strongly disagree). Besides the total
score, the DCS has the following five subscales: uncer-
tainty, informed, values clarity, support and effective
decision. To calculate the total and subscale scores the
item scores will be averaged and multiplied by 25. The
Table 2 Measurement points
Assessment/Questionnaire Baseline (T0) 2 weeks after intake (T1) 2 months after intake (T2)
Primary Outcome Parameter
Decisional Conflict
Decisional Conflict Scale patient X X
VAS patient (additional) X X
VAS clinician (additional) X
Secondary Outcome Parameters
Patient participation in mental health (treatment).
Patient Participation Questionnaire
X X
Shared Decision Making process
SDM-Q-9 Patient and clinician.
X X
Working alliance
PDRQ-9
X X
Adherence to treatment
Drop-out, no-show
EPR EPR
Symptoms-functioning
SQ-48 (=ROM)
X X X
Patients’ characteristics
Patients’ characteristics
(sex, age, educational level, diagnosis, SQ-48 score,
previous treatment at GGz Breburg, length of waiting)
EPD
Motivation
Demand for treatment on their own initiative? (1 item)
X
Achieving personal treatment goals
(1 item)
X
EPR, Electronical Patient Records
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scores thus range from 0 (no decisional conflict) to 100
(extremely high decisional conflict).
The psychometric properties of the English version of
the DCS are adequate. Test-retest reliability (0.81) and
Cronbach alpha (0.78) are high. The scale correlates to
related constructs (knowledge, regret, discontinuance)
and discriminates between groups who make and delay
decisions (construct validity). DCS is responsive to
change between different decision supporting interven-
tions. The predictive validity of the DCS is also demon-
strated [44, 55, 56].
To compare the degree of decisional conflict (or agree-
ment) between patients and clinicians about the decisions
made, at T1 both patients and clinicians fill out a Visual
Analogue Scale (VAS).
Secondary outcome measures
The secondary outcome measures are patient participa-
tion, process of shared decision making, working alliance,
patients’ adherence to treatment and clinical outcome.
The research team developed the Patient Participation
Questionnaire (PPQ), because no accessible, brief instru-
ment was found that measures patient participation in
treatment with good psychometric properties and which
is also suitable to fill out during or just after the intake
process of mental health treatment.
The PPQ measures the role of the patient in treatment
and shared decision making, consists of 14 items and is
filled out by patients. Each item is measured on a five
point Likert scale (1 = totally not applicable to 5 = totally
applicable). Item scores will be summed. A higher score
indicates a more active role of the patient in the inter-
play with the clinician and in mental health treatment.
Three sample items of the PPQ include:
‘Along with my clinician I have described my
treatment targets’.
‘I participate actively in my treatment’.
‘I participate in decisions about my treatment’.
After development, the PPQ was tested on nine clini-
cians and three peers working at GGz Breburg. They
were asked to fill out the questionnaire and were inter-
viewed afterwards for feedback. The aim of testing was
to see if the items are relevant and comprehensible. This
feedback resulted in textual improvements and adjust-
ments in the order of the questions. The psychometric
qualities of the questionnaire will be investigated in the
population of this study: the factor structure, the reliability
(test-retest and internal consistency) and construct (con-
vergent) validity of the instrument [57, 58]. Convergent
validity will be tested using
1) Decisional Conflict Scale (DCS) [55];
2) Visual Analogue Scale (VAS) consisting of one item
filled out by patients, about the active role of the
patient in treatment measured on a scale from 1 to
Fig. 3 Primary and secondary outcome parameters in flow chart
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10 (1 = not at all to 10 = completely). A higher score
means a more active role in mental health
treatment;
3) two items about treatment targets of the Patient
Reported Experience Measure (PREM) for chronical
care [59, 60]. The items describe the joint
formulation of treatment goals and how to achieve
these goals. This self-report questionnaire is filled out
by patients on a 5-point Likert scale (1 = completely
disagree to 5 = completely agree);
4) Shared Decision Making-Questionnaire-9 (SDM-Q-9)
[61–63] and
5) Patient-Doctor Relationship Questionnaire (PDRQ-9)
[64].
The SDM-process will be measured with the Shared De-
cision Making-Questionnaire-9 (SDM-Q-9) [61, 62], which
has Dutch versions for patients and clinicians [18,
63]. Both versions ask the patient and clinician first to
enter the health problem the consultation was about and
which decision was made. The questionnaire continues
with nine items about the steps in the SDM process, scor-
ing at a 6-point Likert scale that ranges from 0 (completely
disagree) to 5 (completely agree). A total score can be cal-
culated by summing the scores of all items. A high score
indicates more SDM. The SDM-Q-9 shows a high reliabil-
ity [61, 62]. The available results about the factorial validity
are also positive [61, 62]. The psychometric testing of the
Dutch version of the SDM-Q-9 [63] demonstrated good
acceptance, internal consistency, and acceptable to good
convergent validity of the versions for patients and physi-
cians. Patients will be asked to complete the SDM-Q-9 at
T1 and T2. At T1 clinicians will complete the same ques-
tions regarding the consultations with their patients.
The PDRQ-9 will measure the working alliance. The
PDRQ-9 consists of 9 items and measures the thera-
peutic aspects of the clinician-patient relationship from
a patient point of view. The items focus on the empathic
style and availability of the clinician and are answered
on a 5-point Likert scale (1 = not at all appropriate to 5
= totally appropriate). Two sample items are: ‘My clin-
ician understands me’ and ‘My clinician and I agree on
the nature of my medical symptoms’. A mean score of
all nine items is calculated. A higher score means more
satisfaction about the relationship. The psychometric
quality of the Dutch PDRQ-9 shows good internal
consistency, adequate test-retest reliability and the ability
to discriminate between patient groups [64].
Next the patients’ adherence to treatment will be
investigated. Adherence can be defined as the extent to
which the patient’s behaviour concur with the advice of
the clinician [9]. In this study adherence is operationa-
lised as the number of missed appointments (no-shows)
and patients who do not want to proceed with treatment
(early treatment drop out). These data will be extracted
from the electronic patient records.
Finally, effects on treatment results will be studied
with the Symptom Questionnaire-48 (SQ-48). This is a
self-report questionnaire for the measurement of
psychological distress, vitality and work functioning and
consists of 48 items. Each item is rated on a 5-points
Likert-scale (0 = Never to 4 = Very often). Five subscales
cover aspects of psychopathology: Depression, Anxiety,
Somatization/Somatic complaints, Social Phobia and
Agoraphobia. In addition, four subscales were con-
structed to assess specific aspects of behaviour and/or
functioning: Aggression, Cognitive problems/complaints,
Work and Vitality. The total score is calculated by sum-
ming 37 items (excluding work and vitality subscale-
items) and ranges from 0 to 148, with higher scores
indicating more psychological distress. The subscales
work and vitality have a different scoring (Work with an-
swering options “not applicable”; Vitality which scoring
is reversed for the positively formulated items).
Research demonstrated the quality of the psychometric
properties of the SQ-48. The internal consistency (reli-
ability) as well as the convergent and divergent validity
among both clinical and nonclinical samples are good
[65]. Research also showed that the SQ-48 has excellent
test-retest reliability and good responsiveness to thera-
peutic change [66].
Treatment integrity
To check the treatment integrity, during the implementa-
tion and period of data collection, process indicators will
be assessed. These indicators will report the degree of
completion of the eHealth modules (registered by research
assistants in the research dbase), number of completed
ROM measurements (data extraction from electronic
patient records) and the extent of using peer support
(registered by peers themselves).
Sample size calculation
This study is designed to detect a medium effect size of
d = 0.5 on the primary outcome parameter between the
intervention and control group. A significance level set
at α = 0.05 and 65 patients per arm will yield a power of
0.80 [67]. Due to the cluster-randomisation at team
level, we will calculate the effective sample size with an
intra cluster correlation coefficient (ICC). The ICC is
a measure of relatedness of responses within a cluster
[68]. When adjusting for clustering within the
matched pair teams of each department we expect an
ICC = 0.01. Using the following formula [68]: Design
Effect (DE) = 1 + (m-1) ICC (0.01) (m = number of
subjects in a cluster), the sample size needs to be 77
patients per arm. We expect about 10% of the partici-
pants to drop out of the study. This requires an
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initial inclusion of 88 patients per arm, which means
that in total 176 patients and on average 44 patients
per centre (22 patients per intake-team per arm) will
need to be included.
Statistical analyses
The data will be analysed according to the intention-to-
treat principle. In addition, a completer case analysis will
be performed.
Descriptive analysis will be conducted to describe
patients’ characteristics (age, gender, educational level,
diagnosis, SQ-48 (ROM) score at T0, motivation for
treatment at T0, previous treatment and length of wait-
ing) to check the similarity between the intervention and
control group. In addition, treatment integrity (degree of
completion of the eHealth modules, number of com-
pleted ROM measurements and the extent of using peer
support) will be described.
Due to the cluster randomisation, the hypotheses will
be tested using multi-level analysis [45], which is also a
flexible statistical method in handling missing data [69].
We assume a three level structure: clusters (depart-
ments), patients and multiple measurements over time
(within patients) [70].
The patients’ and clinicians’ views on the Shared Deci-
sion Making process (SDM-Q-9) and Decisional Conflict
(VAS) will be compared using independent t-tests.
Analyses will be conducted using SPSS 19.0 and
MLwiN 2.21. Reporting of the results of the study will
be in accordance with the CONSORT statement 2010
(extension cluster randomised trials).
Discussion
The described study is designed to test, in a two-arm
cluster-randomised controlled trial, the efficacy of a
digital exploration of patients’ treatment needs and pref-
erences preparing patients and clinicians for the intake
consultations facilitated by Routine Outcome Monitor-
ing (ROM), peer support and training of clinicians, in
terms of the primary outcome the degree of decisional
conflict about choices in treatment. Secondary outcomes
of the study focus on patient participation, shared deci-
sion making process, working alliance, adherence to
treatment and clinical outcomes.
Currently, patients in specialised Dutch mental health
care usually have a dependent, inactive role in the intake
and treatment process with a more dominant, active role
of the clinician [28–31]. This intervention offers the
opportunity for patients to participate actively in their
mental health treatment with an equivalent interplay
with their clinician, which is an important base for
shared decision making aiming to reduce decisional
conflict. Moreover, the new digital intake approach may
improve patients’ adherence to treatment and clinical
outcomes. As previously explained, the intervention
responds to the advantages of shared decision making
[19–29], the promising benefits of patient participa-
tion in mental health treatment [4–9] and the import-
ance of improving the quality and equivalence of the
working alliance [9, 40, 42, 43]. Hence, this initiative
is focused on changing clients’ and clinicians’ roles, at
both sides of the dyad, from the start of treatment.
A strength of this study is the reduced risk of con-
founding by the matched pair design. Randomisation
is conducted at cluster level within each department
between two similar teams of intake-clinicians
(matched pairs). Helping to prevent cross-over ef-
fects, the intervention and control teams of intake-
clinicians participate in different multidisciplinary
team consultations.
A second strength is that the additional data collec-
tion for this research is carried out independent of
the treatment. Separately for this study patients fill
out questions about decisional conflict, participation
in mental health treatment, shared decision making
and the working alliance with the clinician. This re-
sults are not visible at patient level during intake and
treatment. Data collection is conducted by independ-
ent research assistants. This approach diminishes un-
desired influence of the research team or clinicians
on the results, reduces the chance of social desirable
answers and enhances uniformity and quality of the
collected data. Only the outcome parameters no-
show, drop-out and clinical outcome (ROM) will be
collected in the context of treatment.
The third strength of the study is that at T1, both the
patients and clinicians are invited to complete a ques-
tionnaire about decisional conflict and shared decision
making. If there are different views between patients and
clinicians about the application of shared decision mak-
ing, they will be detected and further analysed.
Finally, the study is conducted in four departments
working in two regions and treating different diagnostic
groups (depression, anxiety and personality disorders).
Because the data collection takes place in real world
clinical practice and in several departments the results
will be generalizable to a broader group of mental health
care teams, clinicians and patients with depression, anx-
iety and personality disorders.
The study brings about some limitations that could in-
fluence the results. First, the clinicians are not blinded
for the design. It is possible that clinicians, working in
the control teams, make additional efforts to stimulate
patient participation, to improve the quality of the work-
ing alliance and to applicate shared decision making.
Although, the research assistants are partially blinded
for the study arm, they are less likely to influence the
results, because the outcome parameters are measured
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by self report questionnaires, filled out by patients and
clinicians. Furthermore, it is not possible to prevent con-
tamination bias completely. There is a chance that
knowledge about and experiences in the new way of
working will cross over from clinicians of the interven-
tion group to the intake-clinicians of the control group.
Cross over effects between patients are unlikely, because
patients of the intervention and control group follow
individual treatment sessions and hence do not meet
and know each other. Besides, probably there will be
personnel changes in the participating teams which may
affect the study and its findings. If this is the case the in-
vestigator will deliberate with the manager of the depart-
ment about the solution and monitors closely that no
switches between intervention and control group will
take place, replacement of a clinician is permitted by the
same discipline and new clinicians in the intervention
group will be trained. Finally, to discuss the results of
the intake module, in the intervention group the initial
intake consult takes thirty minutes extra time compared
to the control group. This extra time with the clinician
could be a confounder, because it may enable patients to
become more actively involved in the dialogue about
their own treatment.
The findings from this study will provide valuable
information with regard to the efficacy of a digital
intake approach facilitated by ROM, peer support and
training of clinicians. The study will answer the
question whether this intervention helps to reduce
decisional conflict and enhance patient participation,
shared decision making, working alliance, adherence to
treatment and clinical outcomes. The findings of this
study may give an evidence base for future eHealth
initiatives in the intake process, which may contribute to
the roll out of such interventions aiming to improve the
participation of patients in decision making about their
mental health treatment.
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